Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

Author:

Press Michael F.1,Seoane Jose A.2,Curtis Christina2,Quinaux Emmanuel3,Guzman Roberta1,Sauter Guido4,Eiermann Wolfgang5,Mackey John R.6,Robert Nicholas7,Pienkowski Tadeusz8,Crown John9,Martin Miguel10,Valero Vicente11,Bee Valerie12,Ma Yanling1,Villalobos Ivonne1,Slamon Dennis J.13

Affiliation:

1. Norris Comprehensive Cancer Center, University of Southern California, Los Angeles

2. Departments of Medicine & Genetics, Stanford University, Stanford, California

3. International Drug Development Institute, Louvain-la-Neuve, Belgium

4. University of Hamburg, Hamburg, Germany

5. Frauenklinik vom Roten Kreuz, Munich, Germany

6. Department of Oncology, University of Alberta, Edmonton, Canada

7. Virginia Cancer Specialists/US Oncology Research Network, Fairfax, Virginia

8. Postgraduate Medical Education Center, Warsaw, Poland

9. Irish Cooperative Oncology Research Group, St Vincent’s University Hospital, Dublin, Ireland

10. Instituto de Investigación Sanitaria Gregorio Marañón, CIBERONC, GEICAM, Universidad Complutense, Madrid, Spain

11. The University of Texas, M.D. Anderson Cancer Center, Houston, Texas

12. Cancer International Research Group/Translational Research in Oncology, Paris, France

13. Department of Medicine, Geffen School of Medicine at University of California Los Angeles, Los Angeles

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3